Chronic niche inflammation in endometriosis-associated infertility: Current understanding and future therapeutic strategies

Yi Heng Lin, Ya Hsin Chen, Heng Yu Chang, Heng Kien Au, Chii Ruey Tzeng, Yen Hua Huang

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Endometriosis is an estrogen-dependent inflammatory disease that affects up to 10% of women of reproductive age and accounts for up to 50% of female infertility cases. It has been highly associated with poorer outcomes of assisted reproductive technology (ART), including decreased oocyte retrieval, lower implantation, and pregnancy rates. A better understanding of the pathogenesis of endometriosis-associated infertility is crucial for improving infertility treatment outcomes. Current theories regarding how endometriosis reduces fertility include anatomical distortion, ovulatory dysfunction, and niche inflammation-associated peritoneal or implantation defects. This review will survey the latest evidence on the role of inflammatory niche in the peritoneal cavity, ovaries, and uterus of endometriosis patients. Nonhormone treatment strategies that target these inflammation processes are also included. Furthermore, mesenchymal stem cell-based therapies are highlighted for potential endometriosis treatment because of their immunomodulatory effects and tropism toward inflamed lesion foci. Potential applications of stem cell therapy in treatment of endometriosis-associated infertility in particular for safety and efficacy are discussed.

Original languageEnglish
Article number2385
JournalInternational Journal of Molecular Sciences
Volume19
Issue number8
DOIs
Publication statusPublished - Aug 13 2018

Fingerprint

Endometriosis
Stem cells
Infertility
Inflammation
stem cells
tropism
therapy
implantation
Estrogens
fertility
Cell- and Tissue-Based Therapy
gametocytes
uterus
estrogens
pathogenesis
ovaries
Defects
pregnancy
Therapeutics
lesions

Keywords

  • Endometriosis
  • Immunomodulation
  • Infertility
  • Inflammation
  • Mesenchymal stem cell
  • Niche

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Chronic niche inflammation in endometriosis-associated infertility : Current understanding and future therapeutic strategies. / Lin, Yi Heng; Chen, Ya Hsin; Chang, Heng Yu; Au, Heng Kien; Tzeng, Chii Ruey; Huang, Yen Hua.

In: International Journal of Molecular Sciences, Vol. 19, No. 8, 2385, 13.08.2018.

Research output: Contribution to journalReview article

@article{f9753ef633cc4d6086aa796c5431bca3,
title = "Chronic niche inflammation in endometriosis-associated infertility: Current understanding and future therapeutic strategies",
abstract = "Endometriosis is an estrogen-dependent inflammatory disease that affects up to 10{\%} of women of reproductive age and accounts for up to 50{\%} of female infertility cases. It has been highly associated with poorer outcomes of assisted reproductive technology (ART), including decreased oocyte retrieval, lower implantation, and pregnancy rates. A better understanding of the pathogenesis of endometriosis-associated infertility is crucial for improving infertility treatment outcomes. Current theories regarding how endometriosis reduces fertility include anatomical distortion, ovulatory dysfunction, and niche inflammation-associated peritoneal or implantation defects. This review will survey the latest evidence on the role of inflammatory niche in the peritoneal cavity, ovaries, and uterus of endometriosis patients. Nonhormone treatment strategies that target these inflammation processes are also included. Furthermore, mesenchymal stem cell-based therapies are highlighted for potential endometriosis treatment because of their immunomodulatory effects and tropism toward inflamed lesion foci. Potential applications of stem cell therapy in treatment of endometriosis-associated infertility in particular for safety and efficacy are discussed.",
keywords = "Endometriosis, Immunomodulation, Infertility, Inflammation, Mesenchymal stem cell, Niche",
author = "Lin, {Yi Heng} and Chen, {Ya Hsin} and Chang, {Heng Yu} and Au, {Heng Kien} and Tzeng, {Chii Ruey} and Huang, {Yen Hua}",
year = "2018",
month = "8",
day = "13",
doi = "10.3390/ijms19082385",
language = "English",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "8",

}

TY - JOUR

T1 - Chronic niche inflammation in endometriosis-associated infertility

T2 - Current understanding and future therapeutic strategies

AU - Lin, Yi Heng

AU - Chen, Ya Hsin

AU - Chang, Heng Yu

AU - Au, Heng Kien

AU - Tzeng, Chii Ruey

AU - Huang, Yen Hua

PY - 2018/8/13

Y1 - 2018/8/13

N2 - Endometriosis is an estrogen-dependent inflammatory disease that affects up to 10% of women of reproductive age and accounts for up to 50% of female infertility cases. It has been highly associated with poorer outcomes of assisted reproductive technology (ART), including decreased oocyte retrieval, lower implantation, and pregnancy rates. A better understanding of the pathogenesis of endometriosis-associated infertility is crucial for improving infertility treatment outcomes. Current theories regarding how endometriosis reduces fertility include anatomical distortion, ovulatory dysfunction, and niche inflammation-associated peritoneal or implantation defects. This review will survey the latest evidence on the role of inflammatory niche in the peritoneal cavity, ovaries, and uterus of endometriosis patients. Nonhormone treatment strategies that target these inflammation processes are also included. Furthermore, mesenchymal stem cell-based therapies are highlighted for potential endometriosis treatment because of their immunomodulatory effects and tropism toward inflamed lesion foci. Potential applications of stem cell therapy in treatment of endometriosis-associated infertility in particular for safety and efficacy are discussed.

AB - Endometriosis is an estrogen-dependent inflammatory disease that affects up to 10% of women of reproductive age and accounts for up to 50% of female infertility cases. It has been highly associated with poorer outcomes of assisted reproductive technology (ART), including decreased oocyte retrieval, lower implantation, and pregnancy rates. A better understanding of the pathogenesis of endometriosis-associated infertility is crucial for improving infertility treatment outcomes. Current theories regarding how endometriosis reduces fertility include anatomical distortion, ovulatory dysfunction, and niche inflammation-associated peritoneal or implantation defects. This review will survey the latest evidence on the role of inflammatory niche in the peritoneal cavity, ovaries, and uterus of endometriosis patients. Nonhormone treatment strategies that target these inflammation processes are also included. Furthermore, mesenchymal stem cell-based therapies are highlighted for potential endometriosis treatment because of their immunomodulatory effects and tropism toward inflamed lesion foci. Potential applications of stem cell therapy in treatment of endometriosis-associated infertility in particular for safety and efficacy are discussed.

KW - Endometriosis

KW - Immunomodulation

KW - Infertility

KW - Inflammation

KW - Mesenchymal stem cell

KW - Niche

UR - http://www.scopus.com/inward/record.url?scp=85052149543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052149543&partnerID=8YFLogxK

U2 - 10.3390/ijms19082385

DO - 10.3390/ijms19082385

M3 - Review article

AN - SCOPUS:85052149543

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 8

M1 - 2385

ER -